002173 创新医疗
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.788-5.153-1.817-3.783-5.021
总资产报酬率 ROA (%)-0.638-4.189-1.484-3.007-3.963
投入资产回报率 ROIC (%)-0.738-4.820-1.691-3.430-4.500

边际利润分析
销售毛利率 (%)8.9597.80511.4464.3106.736
营业利润率 (%)-6.993-7.394-3.183-11.075-7.923
息税前利润/营业总收入 (%)-7.167-12.666-5.917-12.053-15.341
净利润/营业总收入 (%)-7.185-11.518-4.256-10.370-14.526

收益指标分析
经营活动净收益/利润总额(%)85.45059.32165.472112.33472.402
价值变动净收益/利润总额(%)5.920-1.9685.257-4.524-15.363
营业外收支净额/利润总额(%)2.97040.04726.670-4.41045.315

偿债能力分析
流动比率 (X)1.8921.8642.2532.3942.717
速动比率 (X)1.7801.7342.1242.2412.593
资产负债率 (%)18.52219.36717.98818.57722.216
带息债务/全部投入资本 (%)1.3241.1392.3751.8231.377
股东权益/带息债务 (%)7,078.1878,225.5673,931.3775,086.9346,445.184
股东权益/负债合计 (%)439.649416.119455.706438.085349.924
利息保障倍数 (X)-178.85737.9683.7538.33617.972

营运能力分析
应收账款周转天数 (天)58.78750.07834.49934.21939.520
存货周转天数 (天)19.26620.05322.97624.46321.029